It concluded that this formulation did not increase the risk of musculoskeletal or gastrointestinal disorders, nor increase aspartate aminotransferase or creatine phosphokinase levels, but was associated with a slight but clinically insignificant increase in alanine aminotransferase compared with placebo [76]. Here, GPT is linked to digestive system disorder.